Global Gastroparesis Drugs Market 2017-2021

Tuesday, May 9, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, May 8, 2017 /PRNewswire/ -- About Gastroparesis Drugs

Gastroparesis also known as delayed gastric

emptying, is a disorder that stops or slows the movement of food through the digestive tract. Normally, the vagus nerve controls the stomach muscles, which are responsible for the movement of food in the stomach. These muscles contract to break up the
food and lead to its movement through the gastrointestinal tract. Gastroparesis can be caused due to the damage of vagus nerve by illness or injury. The disease does not have complete remission; however, proper medications along with the changes in diet can provide relief.

Download the full report: https://www.reportbuyer.com/product/4886908/

Technavio's analysts forecast the global gastroparesis drugs market to grow at a CAGR of 3.54% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global gastroparesis drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Gastroparesis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • Cadila Pharmaceuticals • GlaxoSmithKline • Johnson & Johnson • Valeant Other prominent vendors • Evoke Pharma • Teva Pharmaceutical Industries • Theravance Biopharma Market driver • Rising cases of diabetes fueling the prevalence of diabetic gastroparesis. • For a full, detailed list, view our report Market challenge • Difficulty in diagnosis is hampering the medication process. • For a full, detailed list, view our report Market trend • Introduction of novel ways for the treatment of gastroparesis symptoms. • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Methodology Download the full report: https://www.reportbuyer.com/product/4886908/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-gastroparesis-drugs-market-2017-2021-300453685.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook